Table 1.
Alterations | Prevalence (%) | 95% CI |
---|---|---|
Lymphadenopathy | 82.3 | 64.8–92.6 |
Increasing of total proteins and low A/G ratio | 70.6 | 52.2–84.3 |
Skin lesions | 58.8 | 40.8–74.9 |
Ocular lesions | 50.0 | 32.8–67.3 |
Non-regenerative anemia | 50.0 | 32.8–67.3 |
Thrombocytopenia | 50.0 | 32.8–67.3 |
Renal parameters (AZO, CRE, alterations proteins/urinary creatinine) | 20.6 | 9.3–38.4 |
Weight loss | 17.7 | 7.4–35.2 |
Onycogryphosis | 11.8 | 3.8–28.4 |
Leukocytosis/leukopenia | 11.8 | 3.8–28.4 |
Increasing of transaminases | 5.9 | 1.0–21.1 |
Arthritis | 2.9 | 0.2–17.1 |
Epistaxis | 2.9 | 0.2–17.1 |
Splenomegaly | 2.9 | 0.2–17.1 |